SYSTEMATIC REVIEW
Published on 20 Oct 2026
Peri-transplant eculizumab for preventing antibody-mediated rejection in kidney transplant recipients at high immunologic risk: a systematic review with design-stratified evidence synthesis
doi 10.3389/fimmu.2026.1982870
- 739 views
